Publicaciones en colaboración con investigadores/as de Pitié-Salpêtrière Hospital (15)

2024

  1. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

  2. The Hexokinase 1 5'-UTR Mutation in Charcot-Marie-Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering

    International journal of molecular sciences, Vol. 25, Núm. 8

2022

  1. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?

    Brain : a journal of neurology, Vol. 145, Núm. 12, pp. 4178-4192

2021

  1. Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease

    PLoS ONE, Vol. 16, Núm. 1 January

  2. Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

    Neuropharmacology, Vol. 185

  3. MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

    Translational Psychiatry, Vol. 11, Núm. 1

  4. Neuroinvasion of SARS-CoV-2 in human and mouse brain

    Journal of Experimental Medicine, Vol. 218, Núm. 3

2020

  1. Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

  2. Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers

    Neurobiology of Aging, Vol. 96, pp. 22-32

  3. Successful aging: Insights from proteome analyses of healthy centenarians

    Aging, Vol. 12, Núm. 4, pp. 3502-3515

  4. β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification

    Alzheimer's Research and Therapy, Vol. 12, Núm. 1

2012

  1. Une altération de la neurogenèse conduit à des troubles de l'olfaction dans la sclérose en plaques

    Medecine/Sciences, Vol. 28, Núm. 8-9, pp. 683-687

2011

  1. Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis

    Journal of Clinical Investigation, Vol. 121, Núm. 12, pp. 4722-4734

2009

  1. Transplantation of Myelin Forming Cells

    Encyclopedia of Neuroscience (Elsevier Ltd), pp. 1141-1152

2006

  1. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

    Journal of Clinical Investigation, Vol. 116, Núm. 5, pp. 1410-1424